Initial Disclosure. Promptly after the date hereof (and prior to, or simultaneously with the Company delivering a Request to the Investor hereunder), the Company shall file with the SEC a report on Form 8-K or such other appropriate form as determined by counsel to the Company, relating to the transactions contemplated by this Agreement and a preliminary Prospectus Supplement pursuant to Rule 424(b) of the Securities Act disclosing all information relating to the transaction contemplated hereby required to be disclosed therein and an updated Plan of Distribution, including, without limitation, the name of the Investor, the number of Shares being offered hereunder, the terms of the offering, the purchase price of the Shares, and other material terms of the offering, and any other information or disclosure necessary to register the transactions contemplated herein (collectively, the “Initial Disclosure”) and shall provide the Investor with 24 hours to review the Initial Disclosure prior to its filing. Promptly, and in any event no later than two days after each Purchase Notice Date, the Company shall file with the SEC a Prospectus Supplement pursuant to Rule 424(b) of the Securities Act disclosing all information relating to the particular Advance to be disclosed therein, including, without limitation, the number of Shares offered and the purchase price of the Shares, and other material terms of the particular offering, and any other information or disclosure necessary to register the Shares issued pursuant to such Advance.
Initial Disclosure. Within ten (10) days of execution of this Agreement Seller will deliver and communicate the Product Technology, Technical Data and Application Data to Buyer to enable Buyer to exercise its rights under the Agreement set forth in Section 1.3 (A) hereof. Seller will provide Buyer with sufficient technical support to ensure that Buyer may commence use of the Product and Enhanced Product pursuant to this Agreement.
Initial Disclosure. CSS Licensees shall be provided with Technical Specifications as specified in this Article 4. All Membership Categories will be provided with these Procedural Specifications. In addition, Technical Specifications provided to each CSS Licensee shall correspond with its Membership Category (or Categories), as follows.
Initial Disclosure. Within [***] following each Option Year, Codexis will discuss with Merck any Option Improvements which have come to be Controlled by Codexis during the applicable Option Year and which have been identified and are being practiced by Codexis in its own business operations, and will describe all such Option Improvements to Merck in sufficient detail to assist Merck in determining whether to exercise an Option with respect to such Option Improvements. Merck shall have [***] after receipt of the initial disclosure regarding such Option Improvements to request the disclosure of further information Controlled by Codexis with respect to such Option [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. - 19 – Execution Version Improvements (“Option Evaluation Request”). All such disclosures, whether initial or subsequent, shall be considered the Information of Codexis.
Initial Disclosure. Within [***] days after expiration or termination of the Collaboration Term, Arcus shall deliver to Gilead, with respect to each Arcus Program, a written notice including instructions and credentials with which Gilead may access a Data Room containing the data and information (existing and available as of the date of Arcus’s notice) with respect to each Arcus Molecule.
Initial Disclosure. Within [***] days after the end of the Calendar Quarters ending June 30 and December 31:
(i) during the TT Term and, if GSK exercises the Option, during the Improvements TT Term, Codexis’ Alliance Manager shall disclose to GSK’s Alliance Manager [***] Codexis Core Technology Improvements by or on behalf of Codexis, or any Affiliate of Codexis and [***] corresponding Licensed Additional Codexis IP during the applicable half year period, if any; and
(ii) during the TT Term, Codexis’ Alliance Manager shall disclose to GSK’s Alliance Manager [***] Arising Codexis Enzyme Technology and/or Arising Codexis Process Technology by or on behalf of Codexis, or any Affiliate of Codexis and [***] corresponding Licensed Additional Codexis IP during the applicable half year period, if any.
Initial Disclosure. Within [***] days after the end of the Calendar Quarters ending June 30 and December 31, during the TT Term, GSK shall disclose to Codexis’ Alliance Manager [***] Arising GSK Enzyme Technology and Arising GSK Process Technology, if any.
Initial Disclosure. Licensee and Read-Rite acknowledge that Read-Rite has disclosed to Licensee all presently existing Read-Rite Technical Information regarding Inductive R/W Heads and MR Heads. Promptly following the execution of this Agreement, Read-Rite and Licensee will cooperate to establish a schedule for the initial disclosures to Licensee of Read-Rite Technical Information pertaining to Spin Valve Heads and GMR Heads.
Initial Disclosure. The Company shall, on or before 9:30 a.m., New York time, on the first (1st) Business Day after the date of this Agreement, issue a press release (the “Press Release”) reasonably acceptable to the Buyers disclosing all the material terms of the transactions contemplated by the Transaction Documents. On or before 9:30 a.m., New York time, on the first (1st) Business Day after the date of this Agreement, the Company shall file a Current Report on Form 8-K describing all the material terms of the transactions contemplated by the Transaction Documents in the form required by the 1934 Act and attaching all the material Transaction Documents (including, without limitation, this Agreement (and all schedules to this Agreement), the form of Lock-Up Agreement and the form of the Warrants) (including all attachments, the “Initial 8-K Filing”). From and after the filing of the 8-K Filing, the Company shall have disclosed all material, non-public information (if any) provided to any of the Buyers by the Company or any of its Subsidiaries or any of their respective officers, directors, employees or agents in connection with the transactions contemplated by the Transaction Documents. In addition, effective upon the filing of the 8-K Filing, the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors, affiliates, employees or agents, on the one hand, and any of the Buyers or any of their affiliates, on the other hand, shall terminate.
Initial Disclosure. Upon SYMBOL's request, METROLOGIC shall, without additional cost, disclose to SYMBOL all technical service information necessary for the service of METROLOGIC Products purchased hereunder. Such disclosure shall be made from time to time during the term of the applicable Part of Article 11, or upon request by SYMBOL, subsequent to termination or expiration of the applicable Part of Article 11, by the furnishing to SYMBOL of all relevant documents by METROLOGIC pursuant to Section 10 of these Terms and Conditions and by visits to METROLOGIC facilities by SYMBOL as provided hereunder. Disclosure of the technical service information, to the extent such technical service information is in documentary or fixed form, shall be made by delivery of two (2) copies thereof. To the extent the technical service information is not available in such document or fixed form, disclosure shall be made by providing to SYMBOL reasonable technical assistance and consultation to demonstrate and explain the practical use and operation of the technical service procedures, including diagnosis, use of Spare Parts, in such appropriate detail as to permit SYMBOL to make full use of the information for servicing the METROLOGIC Purchasable Product.
